These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24869721)

  • 1. Use of Vibrio cholerae vaccine in an outbreak in Guinea.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Diallo AA; Itama C; Page AL; Quilici ML; Mengel MA; Eiros JM; Serafini M; Legros D; Grais RF
    N Engl J Med; 2014 May; 370(22):2111-20. PubMed ID: 24869721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study.
    Azman AS; Parker LA; Rumunu J; Tadesse F; Grandesso F; Deng LL; Lino RL; Bior BK; Lasuba M; Page AL; Ontweka L; Llosa AE; Cohuet S; Pezzoli L; Sodjinou DV; Abubakar A; Debes AK; Mpairwe AM; Wamala JF; Jamet C; Lessler J; Sack DA; Quilici ML; Ciglenecki I; Luquero FJ
    Lancet Glob Health; 2016 Nov; 4(11):e856-e863. PubMed ID: 27765293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.
    Luquero FJ; Grout L; Ciglenecki I; Sakoba K; Traore B; Heile M; Dialo AA; Itama C; Serafini M; Legros D; Grais RF
    PLoS Negl Trop Dis; 2013; 7(10):e2465. PubMed ID: 24147164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a cholera rapid diagnostic test during a mass vaccination campaign in response to an epidemic in Guinea, 2012.
    Martinez-Pino I; Luquero FJ; Sakoba K; Sylla S; Haile M; Grais RF; Ciglenecki I; Quilici ML; Page AL
    PLoS Negl Trop Dis; 2013; 7(8):e2366. PubMed ID: 23967359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
    Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
    Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea.
    Ciglenecki I; Sakoba K; Luquero FJ; Heile M; Itama C; Mengel M; Grais RF; Verhoustraeten F; Legros D
    PLoS Med; 2013; 10(9):e1001512. PubMed ID: 24058301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of one dose of killed oral cholera vaccine in an endemic community in the Democratic Republic of the Congo: a matched case-control study.
    Malembaka EB; Bugeme PM; Hutchins C; Xu H; Hulse JD; Demby MN; Gallandat K; Saidi JM; Rumedeka BB; Itongwa M; Tshiwedi-Tsilabia E; Kitoga F; Bodisa-Matamu T; Kavunga-Membo H; Bengehya J; Kulondwa JC; Debes AK; Taty N; Lee EC; Lunguya O; Lessler J; Leung DT; Cumming O; Okitayemba PW; Mukadi-Bamuleka D; Knee J; Azman AS
    Lancet Infect Dis; 2024 May; 24(5):514-522. PubMed ID: 38246191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis.
    Ivers LC; Hilaire IJ; Teng JE; Almazor CP; Jerome JG; Ternier R; Boncy J; Buteau J; Murray MB; Harris JB; Franke MF
    Lancet Glob Health; 2015 Mar; 3(3):e162-8. PubMed ID: 25701994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.
    Wierzba TF; Kar SK; Mogasale VV; Kerketta AS; You YA; Baral P; Khuntia HK; Ali M; Kim YH; Rath SB; Bhattachan A; Sah B
    Vaccine; 2015 May; 33(21):2463-9. PubMed ID: 25850019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of a One-Dose versus Two-Dose Oral Cholera Vaccine Regimen in Outbreak Settings: A Modeling Study.
    Azman AS; Luquero FJ; Ciglenecki I; Grais RF; Sack DA; Lessler J
    PLoS Med; 2015 Aug; 12(8):e1001867. PubMed ID: 26305226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
    Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
    N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Quantitative Systematic Review and Meta-Analysis of the Effectiveness of Oral Cholera Vaccine as a Reactive Measure in Cholera Outbreaks.
    Schwerdtle P; Onekon CK; Recoche K
    Prehosp Disaster Med; 2018 Feb; 33(1):2-6. PubMed ID: 29317005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological description of a protracted cholera outbreak in Tonj East and Tonj North counties, former Warrap State, South Sudan, May-Oct 2017.
    Nsubuga F; Garang SC; Tut M; Oguttu D; Lubajo R; Lodiongo D; Lasuba M; Mpairwe A
    BMC Infect Dis; 2019 Jan; 19(1):4. PubMed ID: 30606126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study.
    Franke MF; Ternier R; Jerome JG; Matias WR; Harris JB; Ivers LC
    Lancet Glob Health; 2018 Sep; 6(9):e1028-e1035. PubMed ID: 30103980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress and Challenges in Using Oral Cholera Vaccines to Control Outbreaks: The Médecins Sans Frontières Experience.
    Ciglenecki I; Azman AS; Jamet C; Serafini M; Luquero FJ; Cabrol JC
    J Infect Dis; 2018 Oct; 218(suppl_3):S165-S166. PubMed ID: 30239901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for reactive mass oral cholera vaccinations.
    Reyburn R; Deen JL; Grais RF; Bhattacharya SK; Sur D; Lopez AL; Jiddawi MS; Clemens JD; von Seidlein L
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e952. PubMed ID: 21283614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case-control study in Lusaka, Zambia.
    Sialubanje C; Kapina M; Chewe O; Matapo BB; Ngomah AM; Gianetti B; Ngosa W; Kasonde M; Musonda K; Mulenga M; Michelo C; Sinyange N; Bobo P; Zyambo K; Mazyanga L; Bakyaita N; Mukonka VM
    BMJ Open; 2022 Nov; 12(11):e066945. PubMed ID: 36368745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can oral cholera vaccination play a role in controlling a cholera outbreak?
    Calain P; Chaine JP; Johnson E; Hawley ML; O'Leary MJ; Oshitani H; Chaignat CL
    Vaccine; 2004 Jun; 22(19):2444-51. PubMed ID: 15193408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.
    Kar SK; Sah B; Patnaik B; Kim YH; Kerketta AS; Shin S; Rath SB; Ali M; Mogasale V; Khuntia HK; Bhattachan A; You YA; Puri MK; Lopez AL; Maskery B; Nair GB; Clemens JD; Wierzba TF
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2629. PubMed ID: 24516675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholera vaccine will reduce antibiotic use.
    Okeke IN
    Science; 2009 Aug; 325(5941):674. PubMed ID: 19661401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.